chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The second vaccine, even after 2 weeks, I've had nasty headaches; my throat is now currently hurting,; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 25 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left (Batch/Lot number: unknown) at the age of 25 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "I can't eat spicy food" (unspecified if ongoing), notes: Known allergies: I can't eat spicy food.; "Irritable bowel syndrome" (unspecified if ongoing), notes: other medical history: Irritable bowel syndrome. Concomitant medication(s) included: FLUOXETINE; BUPROPION; HYOSCYAMINE; OMEPRAZOLE. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), when the patient was 25 years old, for Covid-19 immunisation, reaction(s): "sore throat". The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "The second vaccine, even after 2 weeks, I've had nasty headaches"; OROPHARYNGEAL PAIN (non-serious), outcome "unknown", described as "my throat is now currently hurting,". Therapeutic measures were taken as a result of headache. Therapeutic measures were not taken as a result of oropharyngeal pain.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
now has come down with shingles; This case was reported by a other health professional via call center representative and described the occurrence of shingles in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, unknown after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received dose of Shingrix and experienced shingles. The follow up consent was not granted.
eye drooping; exotropia; facial swelling; chills; This is a spontaneous report from a contactable Physician. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date (at unknown age) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Caller is a physician who states she had a female patient who after receiving that Pfizer COVID 19 vaccines experienced some symptoms of left sided chills, left sided facial swelling and left exotropia or eye drooping. This was evaluated by the urgent care the patient went to for symptoms at the time. She is two weeks from her first dose now and many of the symptoms have resolved. She is still experiencing some left sided head chills. The HCP states that this patient is looking for an exemption from receiving the second dose of the vaccine. HCP states that from looking at the website that currently it looks like to only reason for an exemption would be for a severe allergic reaction and she does not believe that this patient's reaction was severe. She would like to know if there is any information on this circumstance or the exemptions for patients to receive the second dose? The outcome of the events head chills was not recovered, for other events was recovered on unknown date.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Local reaction-red,slightly swollen, itchy used OTC 1% hydrocortisone cream-improvement
Chills; General malaise; This is a spontaneous report from a non contactable consumer, the patient. A 44-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 13Apr2021 at 09:30(at the age of 44-year-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient did not have any relevant medical history. Concomitant medications included meloxicam for unknown indication from unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 23Mar2021 at 15:15 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 01:00 the patient experienced chills and general malaise. Therapeutic measures  were not taken as a result of the event. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event chills and general malaise was recovering at the time of the report.  No follow-up attempts are possible, information about lot number cannot be obtained. No further information is expected.
PT RECEIVED ON 2.4.20. sHE BEGIN TO HAVE FACE AND MOUTH SWELLING ON 2.13.20
Vasovagal syncope 14 minutes after receiving vaccine. Hx of vasovagal syncope after IUD insertion
Onset of nausea with vomiting, ictorus, weakness on 07/09/2005.  Significant abdominal pain, dark urine.
Patient felt shaky, like there was swelling and dryness in her throat, along with a little lightheadedness starting approximately 10 minutes after getting her vaccination.  Pt taken to exam room.  1730: 135/79 bp, 72 pulse, 100 O2.  Pt indicated she has issues with medications and certain foods due to celiacs disease.  She also has an allergy to antibiotics.  1742: 125/81 bp, 71 pulse, 99 02.  1759: 109/70, 73 pulse, 99 O2.  1820: 118/79 bp, 71 pulse, 98 O2.  Patient indicated she was still shaky.  Patient had not eaten anything "recently" and normally would have eaten something by this time. Patient indicated she was feeling slightly better.  Advised patient if symptoms should get worse to seek immediate medical attention.  Also gave patient the covid hotline number so that she could speak with another nurse if needed and asked her to contact her PCP before second dose given.
COVID-19; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (COVID-19) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0-2H221B, ER9731 and 018B21A) for COVID-19 vaccination.     Patient had no allergies.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In July 2022, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In July 2022, SARS-CoV-2 test: Positive.         No concomitant medication details was reported.  No treatment medication details was reported.   This case was linked to MOD-2022-679872 (Patient Link).
flu like aches, forehead headache, cramps (similar to menstrual cramps), very swollen lymph nodes, very enlarged and sore to touch breast, lethargic, no appetite
Got Covid-19 infection; heart problem; lot of cough; I have got something else too. I don't know what it is.; develop temperature out of the blue. The highest has been up to 105.; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Got Covid-19 infection), CARDIAC DISORDER (heart problem), COUGH (lot of cough), IMMUNISATION REACTION (I have got something else too. I don't know what it is.) and PYREXIA (develop temperature out of the blue. The highest has been up to 105.) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032F21A, 027L20A and 039K20A) for COVID-19 prophylaxis.     Concurrent medical conditions included COPD, Lung cancer, Arthritis, Psoriasis, Hypertension, Prostate infection and Anginal pain. Concomitant products included PRASUGREL for Anticoagulant therapy, ACETAMINOPHEN for Arthritis, METOPROLOL for Blood pressure, TAMSULOSIN for Prostate infection, HYDROCORTISONE and SELENIUM SULFIDE for Psoriasis, ALBUTEROL SULFATE;IPRATROPIUM BROMIDE, ALCLOMETASONE DIPROPIONATE, IRON, ISOSORBIDE, GLYCERYL TRINITRATE (NITROQUICK), OMEPRAZOLE, EZETIMIBE, VITAMIN D3, PRAVASTATIN SODIUM (PRAVASTATIN NA), UBIDECARENONE (COQ-10) and PROBIOTICS NOS for an unknown indication.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (Got Covid-19 infection), CARDIAC DISORDER (heart problem), COUGH (lot of cough), IMMUNISATION REACTION (I have got something else too. I don't know what it is.) and PYREXIA (develop temperature out of the blue. The highest has been up to 105.). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) (oral) for COVID-19 treatment, at a dose of 300 milligram three times a day; AZITHROMYCIN at a dose of 250 milligram, gave 6 pills, I take 2 the first day and 1 a day for 4 days and Surgery (Quadruple Bypass and 4 stents.) for Cardiac disorder. At the time of the report, COVID-19 (Got Covid-19 infection), CARDIAC DISORDER (heart problem), COUGH (lot of cough), IMMUNISATION REACTION (I have got something else too. I don't know what it is.) and PYREXIA (develop temperature out of the blue. The highest has been up to 105.) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: develop temperature out of the blue. The highest has been up to 105.. On an unknown date, Chest X-ray: found some kind of  smoky looking stuff.         It was reported that ethnicity was reported as Caucasian.  It was reported that after taking paxlovid patient had terrible case of diarrhea, it was almost like dysentery, stools were really dark.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
About 8 days  after receiving vaccine, recipient suffered a mini stroke. He was hospitalized for several days. He was told he had a clogged artery with 60% blockage. They gave him blood thinner. He  recovered  and was released from hospital. He moves much slower  now and receives physical therapy.
PT given Bivalent Covid vaccine as first dose ,  Negative for any s/s PT waited 15 min evaluated by PCP sent home.  PTS 2nd Covid vaccine will be Monovalent.  PTS 3rd Covid Vaccine will be Bivalent
Site: Bruising at Injection Site-Medium, Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Severe, Systemic: Allergic: Itch Generalized-Medium, Additional Details: pt. got 2 vaccinations on the same time (flu shot and Prevnar 20)
A week after recieving the first does, i developed severe headaches. These headaches have been everyday since January 7th. The headaches are resistant to serval over the counter pain relievers and migraine medicine. Recently i experienced stroke symptoms and went to the ER. The ER believed it to be a TIA or a complex migraine as they were unable to see anything on the 3 CTs and 1 MRI they took. The neurologist i followed up with believes it is a complex migraine and is taking steps to try and mitigate the pain, but i have not seen any progress yet. The headaches are extremely debilitating with sensitivity to light and sound, fatigue, sensitivity to heat and cold, extreme anxiety, depression, having difficulty thinking, pain behind the eyes and pain that seems to move around, infrequently numbness of the right side of the face and tongue, and other various symptoms.
Information has been received from a consumer and a school nurse concerning 41 child patients who in approximately 1995 were each vaccinated with a dose of varicella virus vaccine live. In approximately 2003, the patients developed mild cases of chickenpox. Most of the children were in the first grade and had been vaccinated at their private pediatrician's offices in the area. The reporter noted that her elementary school was the only one out of six in the area that has experienced a chickenpox outbreak. The reported notified the elementary school parents of the outbreak. Follow-up information from the nurse indicated that 13 of the reported 41 patients wre not previously vaccinated with a dose of varicella virus vaccine live and all of the cases of chickenpox have recovered. One of the previously vaccinated patients was a 6 year old twin patient (Grade 03: 1B) who on 12-Feb-2003 was vaccinated with a dose of varicella virus vaccine live. On 21-Feb-2003, the patient developed chickenpox. The previously vaccinated patients included two siblings in elementary school who were vaccinated by the same pediatrician and subsequently developed mild outbreaks of chickenpox. The other patients that developed chickenpox post vaccination with varicella virus vaccine live were also identified (WAES #0304USA00974, 0306USA00276, 0305USA00277, and 0309USA01823 through 0309USA01846). Additional information is not expected.
Patient states one week ago he got the flu vaccine to deltoid, 2-3 days later to same upper arm patient felt pressure type of muscle ache on 11/1/22  which soon became both upper arms and upper chest, the next day bilateral arms and torso with this feeling, today 11/4/22 feels he does not have full strength to drip due to muscle pressure in arms and wrist, and today this feeling has moved into hips and some into groin area.  Denies fevers, numbness or tingling.
1st & 2nd day extreme /Joint & musculoskeletal  pain,  head ache, fatigue , short of breath,   Coughing, runny nose, congestion, fever, ringing in ears,  3rd day musculoskeletal & joint pain, inner ear pain, fatigue, cough, throat pain  This is 3rd day and I am still miserable
COVID-19 positive after vaccination.; COVID-19 positive after vaccination.; Had a clot and thrombectomy; This is a spontaneous report from contactable other-HCP (patient). A patient of an unspecified age and gender received bnt162b2 (PFIZER-BIONTEC COVID-19 VACCINE, Solution for injection, Lot Number: Unknown) via an unspecified route of administration on unspecified as a single dose for COVID-19 immunization. Patient's medical history included thrombectomy and concomitant medication was not reported. On an unspecified date, patient had COVID-19 positive after vaccination and had a clot and thrombectomy. Treated with Xaralto and had another clot. Event took place after use of product. The outcome of events was unknown.  Information about lot/batch number has been requested.; Sender's Comments: Based on the limited information currently provided the lack of efficacy of the administered vaccine BNT162B2 and also the causal association between the reported event clot with the usage of the vaccine cannot be excluded. The contributory role of the patient's medical history needs to be taken into consideration. The case will be reassessed once new information is available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
This spontaneous report was received from a registered nurse referring to an unspecified number of patients of unknown age and gender. The patients' pertinent medical history and concurrent conditions were not reported. On an unknown date, the patients' were vaccinated with and improperly stored dose of ROTATEQ (strength and dose were not provided) (lot # L029617 expiration date 19-MAY-2017) oral. The registered nurse stated that ROTATEQ was exposed to the following temperature conditions: 34 F degrees for an unknown period of time. Previous temperature excursion was unspecified. No adverse event was reported and no product quality issue was involved. Additional information has been requested. This is one of several reports received from the same reporter.
Tested covid after having received the first dose/tested positive; Tested covid after having received the first dose/tested positive; other vaccine same date vaccine date: 07Apr2021; other vaccine same date vaccine date: 07Apr2021; This is a spontaneous report received from a contactable consumer (who is also the patient). A 43-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ew0151), via an unspecified route of administration in the left arm, on 07Apr2021 14:00, as single dose, for COVID-19 immunisation. There was no medical history. The patient had no known allergies. The patient did not have COVID-19 prior to vaccination. Concomitant medication included an unspecified vaccine administered on 07Apr2021 (reported as "other vaccine same date vaccine date: 07Apr2021"). There were no other medications in two weeks. The patient tested COVID after having received the first dose on 26Apr2021 10:00 (also reported as "exactly 22 days after having received the first dose"). The patient tested positive for COVID-19 thru COVID oral swab test on 26Apr2021 (also reported as 27Apr2021). No treatment was received for the event. The patient assessed the event as life-threatening. The outcome of the event was not recovered.
Injection site swelling and redness which included inside of the upper arm. Mild flu symptoms. Per Pharmacist recommendation the patient took Benadryl and Tylenol. At 11:10AM on 10/8/16 the patient reported resolution of swelling and absence of flu symptoms. She stated she did not need further medical treatment.
Fatigue, right eye sensation - light tearing right ankle swelling with burning and pickling pains, pain radiating from rt. Ankle to rt. Knee. Mild heart palpation and light shortness of breath.
I had extreme lymph node swelling all the way up until 9 days after getting the vaccine. I also have been dealing with vertigo and I am still dealing with it two months after the vaccine. I have a difficult time doing anything related to bending down because of the vertigo. I have a hard time putting shoes on, driving, etc. I went to a PCP and was just advised to sleep with my head up or I can take a medication, but it won't allow me to drive. I need to go back in for a follow up.
My mother had a doctor's appointment with MD for a flu shot 10:00 am on November 6, 2006. Immediately after the shot at approximately 11:00 am as they were driving away from the office she started gasping for breath, the paramedics were called and they never revived her.
bursitis for couple days then inflammation of small  joints on left then right feet for almost three weeks
Patient reports that a rash began 3 days after the vaccine on her hands. She described as bumps and reported itching. Then rash progressed to her chest, back, and thighs. scaly and red.
Resident received vaccination on 12/29/2020. Records review shows that he had received monoclonal antibody therapy during hospital admission . Receipt of vaccination was contraindicated in this case.
On 4/15/17 around 8pm pt. began experiencing flu-like symptoms including a fever of 101.6 F (oral temp), body aches. Pt. tested for flu/strep on 4/19. Also U/A, all were negative. Pt. noticed rash on 4/20/17 on face, neck, ears/back. Rash did extend to feet on 4-23-17. Rash still present, but not improved.
Extremely itchy eyes; Slight swelling under eyes; Redness of eyes; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF8839) via an unspecified route of administration in the left arm on 11Sep2021 at 12:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications were not reported. On 13Sep2021 the patient experienced extremely itchy eyes, slight swelling under eyes and redness of eyes. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extremely itchy eyes, slight swelling under eyes and redness of eyes was not resolving at the time of this report.
Same day post vax, pt felt ill. R arm red, hot to touch, swollen. Client was S&B. Dr. state had reaction to Pneumonia shot.
FACIAL / LIP INFLAMMATION WITHOUT THROAT SWELLING TREATED WITH DIPHENHYDRAMINE - SWELLING SUBSIDED
Fever of over 101 degrees developed during the night, approximately 12 - 15 hours after receiving second dose. Fever lasted for nearly 24 hours and did not respond to Extra Strength Tylenol.  Allergic red rash appeared over trunk of body overnight following injection, within 12 - 18 hours. Rash continued to spread to inside of arms, thighs, across back and abdomen, and neck. Treating with Benadryl oral and topical. Pain and soreness in arm where injection was received began a few hours after injection, lasting about 24 hours.
Injection site soreness x 3 days, Myalgias and fever (99.2 -100) for three-four days, headaches, fatigue, arthralgias.
Red, itchy rash, commonly referred to as ?covid arm? appeared 1 week after 1st dose at the injection site
Patient developed pain in all joints, a rash on both legs and a fever on day of vaccination. Patient saw physician on 6/17/01 and was prescribed pain pills and hydroxyzine for rash. The patient also complained of dizziness and shortness of breath. As of 6/21/01, the rash was resolving.